NKX6.1 hypermethylation predicts the outcome of stage II colorectal cancer patients undergoing chemotherapy von Chang, Sou‐Yi, Kuo, Chih‐Chi, Wu, Chang‐Chieh, Hsiao, Cheng‐Wen, Hu, Je‐Ming, Hsu, Chih‐Hsiung, Chou, Yu‐Ching, Shih, Yu‐Lueng, Lin, Ya‐Wen

Volltext

Radiofrequency ablation versus surgical resection for the treatment of solitary hepatocellular carcinoma 2 cm or smaller: A cohort study in Taiwan von Wu, Chao-Chuan, Tseng, Chih-Wei, Tseng, Kuo-Chih, Chen, Yen-Chih, Wu, Ta-Wei, Chang, Sou-Yi, Chang, Yao-Jen, Chao, You-Chen, Hsu, Ching-Sheng

Volltext

Daily activity, mood, and quality of life in colorectal cancer patients with chemotherapy‐induced peripheral neuropathy: A mediation effect analysis von Lu, Ling‐Chun, Tsay, Shiow‐Luan, Chang, Sou‐Yi, Chen, Chung‐Ming, Liu, Chieh‐Yu

Volltext

Reliability and validity of the Chinese version neuropathic pain symptom inventory in patients with colorectal cancer von Lu, Ling-Chun, Chang, Sou-Yi, Liu, Chieh-Yu, Tsay, Shiow-Luan

Volltext

Transarterial chemoembolization with or without sorafenib for hepatocellular carcinoma: A real-world propensity score-matched study von Peng, Tzu-Rong, Wu, Ta-Wei, Wu, Chao-Chuan, Chang, Sou-Yi, Chan, Cheng-Yi, Hsu, Ching-Sheng

Volltext

Therapeutic efficacy of nivolumab plus sorafenib therapy in patients with unresectable hepatocellular carcinoma von Peng, Tzu-Rong, Wu, Chao–Chuan, Chang, Sou-Yi, Chen, Yen-Chih, Wu, Ta-Wei, Hsu, Ching-Sheng

Volltext

Abstract 2575: NKX6.1 hypermethylation predicts the outcome of stage II colorectal cancer patients undergoing chemotherapy von Lin, Ya-Wen, Chang, Sou-Yi, Kuo, Chih-Chi, Hsiao, Cheng-Wen, Hsu, Chih-Hsiung, Chou, Yu-Ching, Shih, Yu-Lueng

Volltext